Javitt Jonathan C

Javitt Jonathan C is listed in filings as Chairman and Chief Scientist at NRx Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Sep 10, 2025, including purchase activity. Recent filings connect the profile to NRx Pharmaceuticals, Inc. (NRXP). The current snapshot covers public activity from Dec 18, 2024 to Sep 10, 2025. Reported amounts are shown as $46.8K to $216.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.